Data Supporting SGLT Inhibitors in Kidney Patients - BC Renal Provincewide Rounds (Oct 2020)

Evolving therapies to treat chronic kidney disease - UBC and BCR Province Wide Rounds 10.28.2022See more

Kidney disease and COVID-19 Research – UBC and BC Renal Province Wide Rounds 5.19.2023See more

Nephrology Grand Rounds: SGLT2 InhibitorsSee more

Recent Advances in the Management of CKD – UBC and BC Renal Province Wide Rounds 10.01.2021See more

CKD Management - BC Renal Province-wide Rounds (June 2020)See more

CKD E-Learning - SGLT-2 inhibitors and CKD - 05.19.21See more

Indigenous Kidney Health Programs - BC Renal Province-wide Rounds (June 2020)See more

Advances in Treating Diabetes and Kidney Disease - BC Renal PWR (Feb 2020)See more

Highlights from the 2020 ASN Conference - BC Renal Province-wide RoundsSee more

Educational webinar: New treatments for preventing chronic kidney disease progressionSee more

UofL Dept. of Medicine Grand Rounds: Dr. George Aronoff (Gaspar Carrasquer Lecture)See more

SGLT2 Inhibitors: CV Outcomes Data in Type 2 DiabetesSee more

Assimilating the Evidence in T2DM: Cardiovascular and Renal Outcomes With SGLT2 InhibitorsSee more

ESC 2020: Commentary on the DAPA-CKD Study — Dr Giuseppe GalatiSee more

SGLT2 Inhibitors: Can these drugs slow the progression of chronic kidney disease?See more

SGLT2 Inhibitor Interdisciplinary ForumSee more

DAPA-CKD By Amr El-HusseiniSee more

Preventing CKD and ESKDSee more